X. Forns

Hepatology · 2002–2018

A researcher in the Science corpus: 10 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom X. Forns trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Lavanchy

Who trusts X. Forns overall

  1. Laurent Castéra

Papers from X. Forns's perspective

Ordered by how strongly the researchers X. Forns trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. (Ultrasound in Medicine and Biology)
  2. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. (New England Journal of Medicine)
  3. Sofosbuvir for previously untreated chronic hepatitis C infection. (New England Journal of Medicine)
  4. Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin. (New England Journal of Medicine)
  5. ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis. (New England Journal of Medicine)
  6. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive… (The Lancet)
  7. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. (Gastroenterology)
  8. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. (New England Journal of Medicine)
  9. Sampling variability of liver fibrosis in chronic hepatitis C (Hepatology)
  10. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. (Journal of Clinical Epidemiology)

Their papers